Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.

Mohammed H Moghadasian, Gerald Salen, Jiri J Frohlich, Charles H Scudamore

Journal: Archives of neurology 2002;59(4):527-9

PMID: 11939886

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

This mini-review deals with a new appraisal of cerebrotendinous xanthomatosis. In addition to neurologic symptoms, patients with cerebrotendinous xanthomatosis develop cataracts, diarrhea, Achilles tendon xanthoma, atherosclerotic vascular disease, and many other abnormalities. Although the pathophysiology of the disease is not completely understood, excess production and consequent accumulation of cholestanol in tissues may play a crucial role. Chenodeoxycholic acid is the most effective therapy. The causative role and detrimental effects (at a low plasma level) of cholestanol merit further investigation.

Address: Healthy Heart Program, St Paul's Hospital, Suite 180, 1081 Burrard St, Vancouver, British Columbia, Canada V6Z 1Y6. [email protected]

DOI: 10.1001/archneur.59.4.527

Link outs

Free resources

Medical:

https://medlineplus.gov/braindiseases.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Brain Diseases, Chenodeoxycholic Acid, Cholestanol, Diagnosis, Differential, Humans, Hyperlipoproteinemia Type II, Musculoskeletal Diseases, Sitosterols, Tendons, Xanthomatosis